IL-17B, Agonist of Interleukin-25 receptor, CAS No.rp174284, Agonist of Interleukin-25 receptor

Features and benefits
    Item Number
    rp174284
    Grouped product items
    SKUSizeAvailabilityPrice Qty
    rp174284-500μg
    500μg
    Available within 8-12 weeks(?)
    Production requires sourcing of materials. We appreciate your patience and understanding.
    $1,334.90
    rp174284-1mg
    1mg
    Available within 8-12 weeks(?)
    Production requires sourcing of materials. We appreciate your patience and understanding.
    $2,334.90

    Basic Description

    Product NameIL-17B, Agonist of Interleukin-25 receptor, CAS No.rp174284
    GradeMoligand™
    Specifications & PurityMoligand™
    Action TypeAGONIST
    Mechanism of actionAgonist of Interleukin-25 receptor

    AI Insight

    Product Specifications

    CASrp174284

    Certificates(CoA,COO,BSE/TSE and Analysis Chart)

    C of A & Other Certificates(BSE/TSE, COO):
    Analytical Chart:

    Related Documents

    Reviews

    Customer Reviews

    References

    1. Shi Y, Ullrich SJ, Zhang J, Connolly K, Grzegorzewski KJ, Barber MC, Wang W, Wathen K, Hodge V, Fisher CL et al..  (2000)  A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity..  J Biol Chem,  275  (25): (19167-76).  [PMID:10749887] [10.1021/op500134e]
    2. Moore EE, Presnell S, Garrigues U, Guilbot A, LeGuern E, Smith D, Yao L, Whitmore TE, Gilbert T, Palmer TD et al..  (2002)  Expression of IL-17B in neurons and evaluation of its possible role in the chromosome 5q-linked form of Charcot-Marie-Tooth disease..  Neuromuscul Disord,  12  (2): (141-50).  [PMID:11738356] [10.1021/op500134e]
    3. Alinejad V, Dolati S, Motallebnezhad M, Yousefi M.  (2017)  The role of IL17B-IL17RB signaling pathway in breast cancer..  Biomed Pharmacother,  88  (13): (795-803).  [PMID:28160754] [10.1021/op500134e]
    4. Wu HH, Hwang-Verslues WW, Lee WH, Huang CK, Wei PC, Chen CL, Shew JY, Lee EY, Jeng YM, Tien YW et al..  (2015)  Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines..  J Exp Med,  212  (3): (333-49).  [PMID:25732306] [10.1021/op500134e]

    Solution Calculators